Related Experiment Video
Updated: Dec 4, 2025
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Fronto-orbital metastasis of a prostatic adenocarcinoma
Issam Jandou1,2, Amine Moataz1,2, Yassine Larrache1,2
1University Hospital Center Ibn Rochd, Casablanca, Morocco.
Abstract:
Prostate cancer often spreads to bony sites, but other metastatic sites are exceptional. Brain localization accounts for less than 4% of postmortem cases.The cerebral metastases of a prostatic ADK are rare, the prognosis is unfortunate and the treatment is based on androgen deprivation and radiotherapy. We describe a case of orbital metastasis of prostatic adenocarcinoma and we highlight the diagnostic and therapeutic singularity of this affection.
Insights
Prostate adenocarcinoma rarely metastasizes outside bone. This case highlights an unusual orbital metastasis, presenting unique diagnostic and treatment challenges for this advanced prostate cancer.
Area of Science:
- Oncology
- Urology
- Ophthalmology
Background:
- Prostate adenocarcinoma commonly metastasizes to bone.
- Non-osseous metastases, particularly to the brain, are rare, accounting for less than 4% of cases.
- Cerebral metastases from prostate adenocarcinoma carry a poor prognosis and are typically managed with androgen deprivation and radiotherapy.
Observation:
- This report details an exceptional case of orbital metastasis from prostate adenocarcinoma.
- The patient's presentation involved the orbit, an uncommon site for prostate cancer spread.
- The diagnostic and therapeutic approach for this specific metastasis was unique.
Findings:
- Orbital metastasis of prostate adenocarcinoma is an exceedingly rare clinical presentation.
- The management of such rare metastatic sites requires careful consideration beyond standard treatment protocols.
- This case underscores the diverse metastatic potential of prostate adenocarcinoma.
Implications:
- Highlights the importance of considering rare metastatic sites in advanced prostate cancer diagnosis.
- Suggests the need for tailored treatment strategies for non-osseous prostate cancer metastases.
- Contributes to the understanding of prostate adenocarcinoma's metastatic behavior and clinical management.
